Compass Pathways
A Clinical Scientist at Compass Pathways supports clinical development and scientific oversight of late-stage clinical trials, collaborating with multiple departments to ensure high-quality studies and compliant decision-making.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2016
Compass Pathways is a biotechnology company developing psilocybin-based therapies for treatment-resistant depression and other serious mental health conditions. It conducts clinical research and develops treatment models that combine psychedelic compounds with psychological support.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Compass Pathways.
Compass Pathways didn’t post a salary, so this is our estimate from similar listings.
BREAKING: Second Positive Phase 3 for Compass' Psilocybin, Though Modest Magnitude Raises Questions
3 weeks ago
Oncology Clinical Development Scientist (Director)
Pfizer
Associate Director, Clinical Scientist
Eikon Therapeutics
Oncology Clinical Development Scientist, Director
Pfizer
Senior Clinical Scientist
CRISPR Therapeutics
Oncology Late Stage Clinical Scientist (Senior Manager, Non MD)
Pfizer
Oncology Late Stage Clinical Scientist (Senior Manager, Non MD)
Pfizer